fbpx
  • Home
  • Search Results

Search Results

Open
Kidneys and Liver
17 studies match your search
Open

Tracking the Impact of Kidney Transplant

Have you been listed for kidney transplant at UNC? If so, you may be able to take part in a research study to help us learn how the process of waiting for a kidney transplant impacts you.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Genetics and Genetic Disorders
  • Mental and Emotional Health
  • Transplant
  • and 3 more
Visit Location
100% Remote (online, phone, text)
Open

CONFIDENCE

Have you been diagnosed with chronic kidney disease and type 2 diabetes? If so, you may qualify for a research study to see if two medicines help to treat kidney disease.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Diabetes
  • Kidneys and Liver
  • Rare Diseases
Open

Goodpasture Disease (Anti-GBM) Research Study

Have you been hospitalized for anti-GBM disease (Goodpasture disease)? You may be able to take part in a research study to help us learn if adding a drug to your treatment could help stop inflammation faster and help protect the kidneys.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
  • Lungs and Breathing
Open

VX-147

People with kidney disease that have the APOL1 risk variant are at a greater risk for developing protein in their urine and chronic kidney disease. This research study is being done to determine if the investigational drug, VX-147 can slow or stop the worsening of kidney function as well as target the underlying cause of kidney disease.

Age & Gender
  • 18 years ~ 60 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
  • Rare Diseases
Open

Chronic Kidney Disease and Type 2 Diabetes Treatment Study

Do you have Chronic Kidney Disease that is due to Type 2 Diabetes? You may be able to take part in a research study to help learn about the safety and impact of a study treatment that is injected into one of your kidneys.

Age & Gender
  • 30 years ~ 80 years
  • Male, Female
Study Interest
  • Diabetes
  • Kidneys and Liver
Open

Aurora VOCAL Study for Adolescents with Lupus Nephritis

You are participating in a clinical research study to investigate whether voclosporin (the study drug) added to standard treatment is able to reduce Lupus Nephritis disease activity in adolescents. This study involves 24 weeks of treatment and you will be required to follow specific instructions of the study as explained by your study doctor and team

Age & Gender
  • 12 years ~ 17 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Open

Treatment Study for Non-diabetic Chronic Kidney Disease (FIND-CKD)

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finerenone, is being developed to help people who have long lasting kidney disease, also known as chronic kidney disease (CKD). It works by blocking a certain hormone called aldosterone that causes injury and inflammation in the heart and kidney which is known to play a role in CKD. In this trial, the researchers want to learn if finerenone helps to slow down the worsening of the participants' non-diabetic CKD compared to a placebo. A placebo looks like a trial treatment but does not have any medicine in it. The trial will include about 1,580 men and women who are at least 18 years old.

Age & Gender
  • 18 years ~ 0 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Open

Evaluating Problematic Proteinuria in Kids (EPPIK)

The purpose of the EPPIK study is to gain further experience on the use of sparsentan in children.

Age & Gender
  • 1 years ~ 17 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
  • Rare Diseases
Open

CureGN Diabetes

We still have a lot to learn about why people develop glomerular disease and what the best medicines are to treat these diseases. Diabetes is a common, chronic illness and many people with glomerular disease also have diabetes. Currently, there is no information telling us the best ways to treat patients with both diabetes and glomerular disease, or how to counsel them about prognosis and risks for complications. This substudy of the Cure Glomerulopathy Network brings together information and laboratory specimens from patients with diabetes and glomerular disease to speed up and improve health research for their care.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
  • Rare Diseases
Open

Ravulizumab/placebo for Lupus Nephritis or IgA Nephropathy

The study tests the safety and efficacy of a new type of drug, administered by intravenous infusion, for the treatment of lupus nephritis or IgA Nephropathy. You might be on the drug or on the placebo (no active drug ) and will help to figure out if this new drug is a good alternative or complement to existing drugs.

Age & Gender
  • 18 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research